Rather than inhibiting antioxidant enzymes directly, enhancing SeP may reduce hepatic selenium retention and thereby limit the synthesis of selenoproteins such as GPx1 and GPx4, which support cancer cell survival under oxidative stress. The gene discussed is SELENOS; the disease is cancer.